ReviewTherapeutic advances in hematology2014

Rituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centers.

Tanya M Wildes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.